In Ireland, the Citizens' Assembly recommends decriminalizing drugs
The Irish Citizens’ Assembly on Drug Use recently released a report recommending the decriminalization of drug possession for personal use, marking a radical shift in Irish drug policy.
Led by Paul Reid, the Citizens« Assembly report proposes a »decriminalized” model, advocating a shift from a criminal justice approach to a comprehensive health-focused strategy.
Recommendation of the Assembly
The Assembly, composed of 99 randomly selected citizens, approved a «comprehensive, health-focused approach» to drug possession. This approach involves giving people caught in possession of drugs for personal use «numerous opportunities» to voluntarily engage with health services, in order to minimize or eliminate the possibility of a criminal conviction and a prison sentence for simple drug possession.
Paul Reid emphasized that the Assembly was focusing on the end result, leaving it to the Oireachtas, Ireland’s bicameral parliament, to work out the complex legislative details of implementing effective decriminalization. The report must now be reviewed by the Oireachtas and the government, prompting Paul Reid to call on policymakers to take ownership of the recommendations.
The Taoiseach—Ireland’s prime minister—Leo Varadkar has expressed openness to the idea of considering changes to the country’s drug laws, stating: «I certainly believe that shaming people, blaming them, and criminalizing them is not an effective policy.».
Mr. Varadkar pledged to carefully consider any recommendations and emphasized the need for political courage and leadership to oversee «effective decriminalization.».
Challenges and Legislative Considerations
The path toward drug decriminalization in Ireland is not without obstacles. Members of the assembly and legal experts already disagree on the definition and feasibility of decriminalization.
The international drug situation isn’t helping either: a major EU study on the heroin market recently published warns of the potential negative effects on public health and safety of the shift from opium to synthetic opioids following the decline in poppy production in Afghanistan. The risk is that synthetic substances with side effects far more severe and deadly than those of natural substances will flood the market, a situation exacerbated by prohibition policies.
The Irish government’s response further complicates matters. While the assembly recommends a comprehensive, health-focused approach, the Department of Justice and An Garda Síochána oppose legal changes that go beyond the existing diversion program, which allows for a maximum of two referrals to health services for drug possession.
The government's delay in moving forward with a bill to legalize cannabis possession – up to 7 grams of cannabis and 2.5 grams of resin for personal adult use – adds a new layer of complexity to the ongoing debate.
Delay in the «legalization» of cannabis
Despite the legislature’s efforts to reform drug policy, the Irish government is proposing to delay the vote on the bill to legalize cannabis possession by nine months. Taoiseach Varadkar emphasized the need to avoid blindly adopting models from other countries and suggested a nuanced approach that takes into account the legal context of decriminalization under Irish law.
Critics, including Ryan McHale Crainn of the Irish drug policy reform organization Crainn, have expressed their disappointment at this delay, highlighting the Citizens’ Assembly’s clear calls for change and the overwhelming public support for drug decriminalization. MP Paul Murphy believes that the delay proposed by the government is merely kicking the can down the road and urges it to follow through on its rhetoric of a health-centered approach to drugs.
-
Cannabis in Europe4 weeks ago
Bosnia and Herzegovina Continues to Roll Out Medical Cannabis Following Its Legalization
-
Cannabis in France4 weeks ago
France Submits the Long-Awaited Decree on the Reimbursement of Medical Cannabis to the Council of State
-
Cannabis in the U.S.4 weeks ago
The DEA Begins Hearings on the Federal Rescheduling of Cannabis
-
Business3 weeks ago
China Invests $10 Million in Medical Cannabis in Lebanon
-
Cannabis in Thailand4 weeks ago
Thailand Threatens Cannabis Shops with Severe Penalties
-
Cannabis in Australia3 weeks ago
South Australia is working to identify more water-efficient hemp varieties
-
Exchange4 weeks ago
Glass House will be the second U.S. cannabis company to list on the New York Stock Exchange
-
Cannabis in Africa2 weeks ago
Kenya Denies Rastafarians the Right to Use Cannabis


You must be logged in to post a comment Login